1. Home
  2. RSF vs DRIO Comparison

RSF vs DRIO Comparison

Compare RSF & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RiverNorth Capital and Income Fund

RSF

RiverNorth Capital and Income Fund

HOLD

Current Price

$14.62

Market Cap

59.0M

Sector

Finance

ML Signal

HOLD

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$6.60

Market Cap

60.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSF
DRIO
Founded
2016
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.0M
60.6M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
RSF
DRIO
Price
$14.62
$6.60
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
10.1K
9.1K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
10.61%
N/A
EPS Growth
N/A
1559.02
EPS
N/A
1.25
Revenue
N/A
$7,394,000.00
Revenue This Year
N/A
$20.27
Revenue Next Year
N/A
$47.58
P/E Ratio
N/A
$5.44
Revenue Growth
N/A
43.02
52 Week Low
$14.23
$0.38
52 Week High
$15.07
$17.74

Technical Indicators

Market Signals
Indicator
RSF
DRIO
Relative Strength Index (RSI) 52.49 43.99
Support Level $14.58 $6.28
Resistance Level $14.73 $9.46
Average True Range (ATR) 0.07 0.48
MACD 0.00 -0.00
Stochastic Oscillator 47.59 49.60

Price Performance

Historical Comparison
RSF
DRIO

About RSF RiverNorth Capital and Income Fund

RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: